Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by P. Libby
Thirty‐One Years of Warming and Oxygen Decline in Massachusetts Bay, a Well‐Flushed Non‐Eutrophic Temperate Coastal Waterbody
1 Introduction Observations reveal a pattern of long-term warming and oxygen decline in coastal waterbodies around the world (e.g. Breitburg et al., 2018; Diaz & Rosenberg, 2008). These trends are concurrent with well-documented long-term warming and deoxygenation across the global deep-water oceans driven by climate change (e.g. Keeling et al., 2010; Schmidtko et al., 2017).
Unveiling a novel pyrazolopyrimidine scaffold as a dual COX-2/5-LOX inhibitor with immunomodulatory potential: Design, synthesis, target prediction, anti-inflammatory activity, and ADME-T with docking simulation
Inflammation in the human body serves as a natural defense mechanism that responds to toxins, infections, and injuries affecting cells or tissues. Its primary objectives are to eliminate pathogens, repair damaged cells, and initiate the healing process [1]. Inflammation can be categorized as either acute or chronic, depending on the duration of the immune response to the infection or injury [2].
A multi-target and responsive nanoplatform (MM/ZnS/ATV) combining H2S and atorvastatin for enhanced atherosclerosis therapy
Atherosclerosis (AS) is a chronic inflammatory disease of the arterial walls. The rupture of AS vulnerable plaques often triggers acute thrombosis, acute myocardial infarction, and even sudden death, making it a leading cause of death worldwide [1]. Abnormal accumulation of lipids in the vessel walls triggered by disorder of lipid metabolism, endothelial dysfunction and progressive inflammation is the key factor in the development of atherosclerosis [2], [3].
Elevated plasma levels of factor VIII enhance arterial thrombus formation on erosive smooth muscle cell-rich neointima but not normal intima in rabbits
Introduction Atherothrombosis is usually caused by thrombus formation associated with the disruption of atherosclerotic plaques [1]. There are three morphologies of plaque disruption: plaque rupture, plaque erosion, and ruptured calcified nodules. Of 236 sudden coronary deaths accompanied by acute thrombi, 65 %, 30 %, and 5 % were attributed to plaque rupture, plaque erosion, and ruptured calcified nodules, respectively [2].
COMBINATION OF EICOSAPENTAENOIC ACID (EPA) AND A STATIN INCREASED EXPRESSION OF DETOXIFICATION PROTEINS IN VASCULAR ENDOTHELIAL CELLS DURING INFLAMMATION
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
HIGH-INTENSITY STATINS COMBINED WITH EICOSAPENTAENOIC ACID (EPA) IMPROVES ENDOTHELIAL FUNCTION DURING EXPOSURE TO OXIDIZED LDL
During atherosclerosis, endothelial cell (EC) dysfunction results in reduced nitric oxide (NO) bioavailability and increased cytotoxic peroxynitrite (ONOO−). This loss of NO bioavailability results in abnormal vasodilation and inflammatory changes. Eicosapentaenoic acid (EPA) administered as icosapent ethyl (IPE) reduced cardiovascular (CV) events in high-risk patients treated with statins (REDUCE-IT). We tested the effects of high-intensity statins and EPA in ECs exposed to oxidized LDL (oxLDL).
INCREASED EICOSAPENTAENOIC ACID TO ARACHIDONIC ACID (EPA/AA) RATIO IN BRAIN ENDOTHELIAL CELLS ASSOCIATED WITH REDUCED EXPRESSION OF NEUTROPHIL DEGRANULATION PROTEINS DURING INFLAMMATION
Endothelial cell (EC) dysfunction results in inflammation and increased atherothrombotic risk, including stroke. The omega-3 fatty acid (FA) eicosapentaenoic acid (EPA) improves arterial compliance in a manner predicted by circulating EPA/AA ratios, an indicator of cardiovascular (CV) risk. Treatment with icosapent ethyl (IPE), a formulation of highly purified EPA, reduced composite CV events, including stroke, in REDUCE-IT that correlated with on-treatment EPA levels.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with P.
Contact P., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack